Article Information
History
- October 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shalini Dogra1,2,
- Branden J. Stansley1,2,
- Zixiu Xiang1,2,
- Weilun Qian3,
- Rocco G. Gogliotti4,
- Ferdinando Nicoletti5,6,
- Craig W. Lindsley1,2,7,8,
- Colleen M. Niswender1,2,9,
- Max E. Joffe1,2,7,† and
- P. Jeffrey Conn1,2,7,9,†
- 1Department of Pharmacology, Vanderbilt University, Nashville, TN 37232, USA
- 2Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, TN 37232, USA
- 3Vanderbilt University, Nashville, TN 37232, USA
- 4Molecular Pharmacology and Neuroscience Department, Loyola University Chicago, Maywood, IL, 60153, USA
- 5IRCCS Neuromed, Pozzilli, Italy
- 6Department of Physiology and Pharmacology, University Sapienza of Roma, Roma, Italy
- 7Vanderbilt Center for Addiction Research, Vanderbilt University, Nashville, TN, 37232, USA
- 8Department of Chemistry, Vanderbilt University, Nashville, TN 37232, USA
- 9Vanderbilt Kennedy Center, Vanderbilt University, Nashville, TN 37232, USA
- ↵†Correspondence to: Max E. Joffe, Ph.D., Research Instructor, Department of Pharmacology, Vanderbilt University, 12475E MRB4, Nashville, TN 37232-0697, Tel. (615) 322-6730, Fax. (615) 343-3088, E-Mail: max.joffe{at}vanderbilt.edu, Twitter: @mejoffe, Ph.D. P. Jeffrey Conn, Ph.D., Lee E. Limbird Professor of Pharmacology Director, Warren Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, 1205 Light Hall, Nashville, TN 37232-0697, Tel. (615) 936-2478, Fax. (615) 343-308,8 E-Mail: jeff.conn{at}vanderbilt.edu